News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wheadon David E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2023 |
4
| Wheadon David E. (Director) has filed a Form 4 on Sotera Health Co|
Txns:
| Granted 15,712 shares
@ $0 |
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Wheadon David E. (Director) has filed a Form 4 on Sotera Health Co|
Txns:
| Granted 9,336 shares
@ $0 |
|
| 05/28/2021 |
3
| Wheadon David E. (Director) has filed a Form 3 on Sotera Health Co |
| 04/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/03/2020 |
4
| Wheadon David E. (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $94.56, valued at
$2.4M
|
|
| 12/03/2020 |
3
| Wheadon David E. (Director) has filed a Form 3 on Karuna Therapeutics, Inc. |
| 09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2020 |
4
| Wheadon David E. (Director) has filed a Form 4 on Assertio Holdings, Inc.|
Txns:
| Granted 237,500 shares
@ $0 |
|
| 10/01/2019 |
4
| Wheadon David E. (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 145,038 options to buy
@ $0 |
|
| 10/01/2019 |
3
| Wheadon David E. (Director) has filed a Form 3 on Assertio Therapeutics, Inc |
|
|